Edward Morrow Atkinson III, EVP, Chief Technical Ops. Off: Vertex Pharmaceuticals VRTX Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $386,996.56
Shares · price: 817 sh · $473.68 a share
Held after: 20,727 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Trade date: 26/02/18
Filed: 26/02/19
Days to filing: 1 days

Sold 3.8% of holdings

Share of holding sold: 3.8%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Edward Morrow Atkinson III's recent trades

Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/26
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/25
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$994.1K
2,031 sh
$994.1K
Filed 02/19
Traded 02/17
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/18
Traded 02/18
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$994.1K
2,031 sh
$994.1K
Filed 02/17
Traded 02/17

Edward Morrow Atkinson III, Chief Officer — sold $387K of Vertex Pharmaceuticals VRTX · 3.8% of holdings · 10b5-1 plan | Whalegun